Form 4: AEHR Test Systems Director Rhea Posedel Granted 10,575 Restricted Stock Units

AEHR Test Systems Director Rhea J. Posedel was granted 10,575 shares of common stock in the form of restricted stock units, increasing direct beneficial ownership to 71,163 shares.

Summary

• Director Rhea J. Posedel of AEHR Test Systems was granted 10,575 shares of common stock as restricted stock unit awards on July 2, 2025.
• These restricted stock units will vest in eight equal quarterly installments, with one-eighth of the total shares vesting at the end of each three full calendar months following the grant date, contingent on continued service as a Board Director.
• Following this transaction, Rhea J. Posedel's direct beneficial ownership of common stock is 71,163 shares, which includes unvested restricted stock units.
• Indirect beneficial ownership through a Trust remains at 470,977 shares.
• Previous distributions from the ESOP plan for Rhea Posedel include 3,408 shares on November 4, 2024, at $11.23 per share for CY 2024, and 1,409 shares on April 2, 2025, at $7.84 per share for CY 2025.
• An additional 18,115 shares were received on April 25, 2025, at $8.76 per share due to the termination of the Company's ESOP plan.

Sentiment

Score: 6

Explanation: The document reports a standard equity grant to a director, which is generally a neutral to slightly positive event as it aligns director interests with shareholders. No negative financial or operational news is present.

Positives

• The grant of 10,575 restricted stock units to a director aligns management's interests with shareholders, as vesting is tied to continued service and potential stock price appreciation.
• Increased direct beneficial ownership by a director demonstrates confidence in the company's future.

Risks

• The vesting of the restricted stock units is contingent upon Rhea J. Posedel's continued service as a member of the Board of Directors.

Future Outlook

The restricted stock units granted to Director Rhea J. Posedel are scheduled to vest in eight equal quarterly installments over a two-year period, contingent on continued service as a Board Director, indicating future share acquisitions.

Industry Context

This filing represents a routine insider transaction disclosure, common for publicly traded companies where directors receive equity compensation. It reflects standard corporate governance practices for aligning director incentives with shareholder value.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of restricted stock units to a director aligns their interests with shareholders, as the value of the compensation is tied to the company's stock performance and continued service.

Next Steps

• Continued vesting of the 10,575 restricted stock units in quarterly installments over the next two years, provided Rhea J. Posedel remains a Board Director.

Key Dates

Keywords

AEHR Test Systems, AEHR, Form 4, SEC filing, insider transaction, director compensation, restricted stock units, RSU, beneficial ownership, ESOP, equity compensation